AU2022245193A1 - Kv1.3 blockers - Google Patents

Kv1.3 blockers Download PDF

Info

Publication number
AU2022245193A1
AU2022245193A1 AU2022245193A AU2022245193A AU2022245193A1 AU 2022245193 A1 AU2022245193 A1 AU 2022245193A1 AU 2022245193 A AU2022245193 A AU 2022245193A AU 2022245193 A AU2022245193 A AU 2022245193A AU 2022245193 A1 AU2022245193 A1 AU 2022245193A1
Authority
AU
Australia
Prior art keywords
amino acid
seq
nle
ion channel
channel blocker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022245193A
Other languages
English (en)
Inventor
Henrik Fischer MUNCH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zealand Pharma AS
Original Assignee
Zealand Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma AS filed Critical Zealand Pharma AS
Publication of AU2022245193A1 publication Critical patent/AU2022245193A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2022245193A 2021-03-23 2022-03-22 Kv1.3 blockers Pending AU2022245193A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21164384 2021-03-23
EP21164384.6 2021-03-23
EP21213431 2021-12-09
EP21213431.6 2021-12-09
PCT/EP2022/057533 WO2022200374A1 (en) 2021-03-23 2022-03-22 Kv1.3 blockers

Publications (1)

Publication Number Publication Date
AU2022245193A1 true AU2022245193A1 (en) 2023-09-07

Family

ID=80952156

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022245193A Pending AU2022245193A1 (en) 2021-03-23 2022-03-22 Kv1.3 blockers

Country Status (12)

Country Link
US (1) US20240182531A1 (cg-RX-API-DMAC7.html)
EP (1) EP4314024A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024511449A (cg-RX-API-DMAC7.html)
KR (1) KR20230159403A (cg-RX-API-DMAC7.html)
AU (1) AU2022245193A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023019022A2 (cg-RX-API-DMAC7.html)
CA (1) CA3208713A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023002590A1 (cg-RX-API-DMAC7.html)
IL (1) IL305219A (cg-RX-API-DMAC7.html)
MX (1) MX2023010930A (cg-RX-API-DMAC7.html)
TW (1) TW202304957A (cg-RX-API-DMAC7.html)
WO (1) WO2022200374A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4604984A1 (en) * 2022-10-18 2025-08-27 Zealand Pharma A/S Inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
GB0414272D0 (en) 2004-06-25 2004-07-28 Cellpep Sa OsK1 derivatives
EP2474316B1 (en) 2004-10-07 2016-04-06 The Regents of The University of California Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
US7833979B2 (en) 2005-04-22 2010-11-16 Amgen Inc. Toxin peptide therapeutic agents
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
US8429751B2 (en) 2009-03-13 2013-04-23 Trustwave Holdings, Inc. Method and apparatus for phishing and leeching vulnerability detection
NZ709913A (en) 2013-01-25 2019-05-31 Janssen Biotech Inc Kv1.3 antagonists and methods of use
JP2016527250A (ja) 2013-07-22 2016-09-08 キネタ ワン リミテッド ライアビリティ カンパニーKineta One,Llc 毒素系治療用ペプチド及びその医薬組成物の眼科的使用
US20180264080A1 (en) 2015-01-09 2018-09-20 Kineta One, Llc TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION
EP4031162A1 (en) * 2019-09-20 2022-07-27 Zealand Pharma A/S Kv1.3 blockers

Also Published As

Publication number Publication date
US20240182531A1 (en) 2024-06-06
CA3208713A1 (en) 2022-09-29
EP4314024A1 (en) 2024-02-07
JP2024511449A (ja) 2024-03-13
CL2023002590A1 (es) 2024-03-15
IL305219A (en) 2023-10-01
BR112023019022A2 (pt) 2023-10-17
WO2022200374A1 (en) 2022-09-29
KR20230159403A (ko) 2023-11-21
TW202304957A (zh) 2023-02-01
MX2023010930A (es) 2023-09-28

Similar Documents

Publication Publication Date Title
US11780893B2 (en) Kv1.3 blockers
KR102502040B1 (ko) 아실화 glp-1/glp-2 이중 효능제
JP6469590B2 (ja) Kv1.3アンタゴニスト及び使用方法
WO2021126695A1 (en) Incretin analogs and uses thereof
WO2018104558A1 (en) Acylated glp-1/glp-2 dual agonists
EP3551652A1 (en) Glp-1/glp-2 dual agonists
JP6985151B2 (ja) プロトキシン−ii変異体及びその使用方法
TW200302278A (en) Corticotropin releasing factor 2 receptor agonists
EP4314024A1 (en) Kv1.3 blockers
RU2825633C1 (ru) БЛОКАТОРЫ Kv1.3
WO2004099238A1 (en) NOVEL mu-CONOTOXIN PEPTIDES
EP4604984A1 (en) Inhibitors
CN117255798A (zh) Kv1.3阻断剂
AU2023383552A1 (en) Methods of treating obesity with an mc4r agonist
CN111094357A (zh) 一类新的Bcl10聚合抑制剂及其应用